Cross-Sectional
Answers are grounded in this paper and cite their sources.
A ccumulating research suggests thatlow 25-hydroxyv i t amin D3[25(OH)D] concentrations may be inversely associated with type 2 diabetes (1–3), metabolic syndrome (4,5), insulin resistance (6), and cardiovascular disease (CVD) (7). Much remains to be learned, how-ever, about the relationships between vi-tamin D status, metabolic syndrome, and CVD. Furthermore, the published data in humans arguing that hypovitaminosis D is a CVD risk factor remain conflicting (8,9). Because this topic has received scant attention and the available information on associations between vitamin D status and CVD among type 2 diabetic adults was lacking, we examined the relationships between serum 25(OH)D concentrations and prevalent CVD in type 2 diabetic adults.
No takes yet. Share an insight, caveat, or question.
Cigolini et al. (2006) conducted a cross-sectional in Type 2 diabetes. Serum 25-hydroxyvitamin D3 [25(OH)D] concentrations was evaluated on Prevalent cardiovascular disease (CVD).
Synapse has enriched 10 related papers. Consider them for comparative context: